Amgen Inc Gets a Buy Rating from Cowen & Co.

Cowen & Co. analyst Eric Schmidt maintained a Buy rating on Amgen Inc (NASDAQ: AMGN) today and set a price target of $204. The company’s shares opened today at $171.94. According to More »

Analysts’ Top Healthcare Picks: DRNA, EPZM

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Dicerna Pharma (NASDAQ: DRNA) and Epizyme (NASDAQ: EPZM) with bullish sentiments. Dicerna Pharma (NASDAQ: More »